Results 61 to 70 of about 50,884 (170)
Journal of Cardiovascular Pharmacology and Therapeutics, 2022 Background: Patients suffering from heart failure (HF) and iron deficiency (ID) have worse outcomes. Treatment with intra-venous (IV) ferric carboxymaltose has been shown to reduce HF rehospitalizations and to improve functional capacity and symptoms in ...
Itay Borreda MD +3 more
doaj +1 more source
Internal Medicine Journal, Volume 56, Issue 9, Page 1536-1543, September 2026.Abstract Background Utilisation of intravenous iron is increasingly recognised as a viable option for treating iron deficiency, especially when oral iron is ineffective or intolerable. However, there are no updated data on the longitudinal trends of utilisation of intravenous iron among women of reproductive age (18–44) in Australia Aims The aim of ...
Gizat M. Kassie +7 more
wiley +1 more source
Hematology, Transfusion and Cell TherapyIntravenous iron formulations differ in benefits and risks that evolve across clinically relevant timepoints. A comprehensive network meta-analysis of randomized trials compared different intravenous iron formulations with oral iron and with each other ...
Francino Machado de Azevedo Filho +4 more
doaj +1 more source
Internal Medicine Journal, Volume 56, Issue 9, Page 1500-1509, September 2026.Abstract Parenteral iron is widely prescribed by medical practitioners, with more than 600 000 outpatient prescriptions dispensed in 2025 through the Australian Pharmaceutical Benefits Scheme. While intravenous iron has transformed the management of iron deficiency, hypophosphataemia is now recognised as a common complication, with incidences reported ...
Brenda Ta +3 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 8, August 2026.ABSTRACT Depressive symptoms in primary care often arise from a complex interplay of hormonal, biological, metabolic, psychosocial, and lifestyle factors. We present the case of a 41‐year‐old woman whose depressive symptoms began three months postpartum after her second pregnancy and persisted for approximately five years.
Leonora Muhadri, Hong Phan
wiley +1 more source
Study to Evaluate the Efficacy of Ferric Carboxymaltose Vs Iron Sucrose in Postpartum Cases with Iron Deficiency Anemia [PDF]
, 2020 BACKGROUND: Anemia is one of the most common yet a manageable problem among the pregnant women worldwide, the global incidence of anemia is 1.62 billion which contributes to maternal and perinatal morbidity and mortality. This study aims to compare the
Narmadhapriya, A
core
Ferric Carboxymaltose in the Treatment of Anemia in Patients with Locally Advanced Colon Cancer
Креативная хирургия и онкологияIntroduction. The incidence of anemia in colorectal cancer patients reaches 30–67% depending on the stage and location of the tumor; the presence of anemia adversely affects the short-term and long-term results of radical treatment.
D. O. Kornev +3 more
doaj +1 more source
Clinical Transplantation, Volume 40, Issue 7, July 2026.ABSTRACT Background Roxadustat is an oral hypoxia‐inducible factor prolyl‐hydroxylase inhibitor. Recent studies have shown no inferiority of roxadustat compared to erythropoietin in chronic kidney disease and in post‐transplant patients. We evaluated roxadustat versus erythropoiesis‐stimulating agents (ESAs) in very early posttransplant patients ...
Paolo Randone +10 more
wiley +1 more source
, 2020 Importance Intravenous iron enables rapid correction of iron-deficiency anemia, but certain formulations induce fibroblast growth factor 23–mediated hypophosphatemia.
Econs, Michael J. +10 more
core +1 more source
Treatment of iron deficiency anemia in the preoperative preparation of patients with uterine myoma
Медицинский совет, 2015 Iron deficiency anemia (IDA) is one of the most common conditions in patients with uterine myoma. The purpose of the study was to evaluate efficacy and safety of intravenous administration of ferric carboxymaltose in patients with iron deficiency anemia ...
T. A. Fedorova +4 more
doaj +1 more source